Effectiveness of mRNA COVID-19 Monovalent and Bivalent Vaccine Booster Doses Against Omicron Severe Outcomes Among Adults Aged ≥50 Years in Ontario, Canada: A Canadian Immunization Research Network Study

被引：7
|
作者：
Grewal, Ramandip [1 ,2 ,3 ]
Buchan, Sarah A. [1 ,2 ,3 ,4 ]
Nguyen, Lena [4 ]
Nasreen, Sharifa [2 ,4 ]
Austin, Peter C. [4 ,5 ]
Brown, Kevin A. [1 ,2 ,4 ]
Gubbay, Jonathan [1 ,6 ]
Lee, Nelson [2 ,7 ]
Schwartz, Kevin L. [1 ,2 ,4 ]
Tadrous, Mina [8 ]
Wilson, Kumanan [9 ,10 ,11 ]
Wilson, Sarah E. [1 ,2 ,3 ,4 ]
Kwong, Jeffrey C. [1 ,2 ,3 ,4 ,12 ,13 ]
机构：
[1] Publ Hlth Ontario, Toronto, ON, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Univ Toronto, Ctr Vaccine Preventable Dis, Toronto, ON, Canada
[4] ICES, Toronto, ON, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[6] British Columbia Childrens & Womens Hlth Ctr, Dept Pathol & Lab Med, Vancouver, BC, Canada
[7] Womens Coll Hosp, Inst Hlth Syst Solut & Virtual Care, Toronto, ON, Canada
[8] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[9] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[10] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
[11] Bruyere Res Inst, Ottawa, ON, Canada
[12] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada
[13] Univ Hlth Network, Toronto Western Family Hlth Team, Toronto, ON, Canada
来源：
JOURNAL OF INFECTIOUS DISEASES | 2024年 / 229卷 / 02期
基金：
加拿大健康研究院;
关键词：
bivalent; COVID-19; mRNA; vaccine effectiveness; Omicron;
D O I：
10.1093/infdis/jiad419
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We estimated the effectiveness of booster doses of monovalent and bivalent mRNA COVID-19 vaccines against Omicron-associated severe outcomes among adults aged >= 50 years in Ontario, Canada. Monovalent and bivalent mRNA COVID-19 booster doses provided similar strong initial protection against severe outcomes. Uncertainty remains around waning of protection from these vaccines. Shortly after bivalent mRNA COVID-19 vaccines were introduced, monovalent and bivalent booster doses provided similar strong initial protection against severe outcomes among Ontario community-dwelling adults aged >= 50 years. Uncertainty remains around waning of protection.
引用
收藏
页码：394 / 397
页数：4
相关论文
共 50 条
  • [21] Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States
    Wilson, Amanda
    Rahai, Neloufar
    Beck, Ekkehard
    Beebe, Elisha
    Conroy, Brian
    Esposito, Daina
    Govil, Priya
    Kopel, Hagit
    Lu, Tianyi
    Mansi, James
    Marks, Morgan A.
    Mues, Katherine E.
    Shah, Rohan
    Skornicki, Michelle
    Sun, Tianyu
    Toyip, Astra
    Yousefi, Mitra
    Martin, David
    Araujo, Andre B.
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (01) : 199 - 216
  • [22] Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023
    Decuir, Jennifer
    Surie, Diya
    Zhu, Yuwei
    Lauring, Adam S.
    Gaglani, Manjusha
    Mcneal, Tresa
    Ghamande, Shekhar
    Peltan, Ithan D.
    Brown, Samuel M.
    Ginde, Adit A.
    Steinwand, Aimee
    Mohr, Nicholas M.
    Gibbs, Kevin W.
    Hager, David N.
    Ali, Harith
    Frosch, Anne
    Gong, Michelle N.
    Mohamed, Amira
    Johnson, Nicholas J.
    Srinivasan, Vasisht
    Steingrub, Jay S.
    Khan, Akram
    Busse, Laurence W.
    Duggal, Abhijit
    Wilson, Jennifer G.
    Qadir, Nida
    Chang, Steven Y.
    Mallow, Christopher
    Kwon, Jennie H.
    Exline, Matthew C.
    Shapiro, Nathan I.
    Columbus, Cristie
    Vaughn, Ivana A.
    Ramesh, Mayur
    Safdar, Basmah
    Mosier, Jarrod M.
    Casey, Jonathan D.
    Talbot, H. Keipp
    Rice, Todd W.
    Halasa, Natasha
    Chappell, James D.
    Grijalva, Carlos G.
    Baughman, Adrienne
    Womack, Kelsey N.
    Rhoads, Jillian P.
    Swan, Sydney A.
    Johnson, Cassandra
    Lewis, Nathaniel
    Ellington, Sascha
    Dawood, Fatimah S.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (11)
  • [23] Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022
    DeSilva, Malini B.
    Mitchell, Patrick K.
    Klein, Nicola P.
    Dixon, Brian E.
    Tenforde, Mark W.
    Thompson, Mark G.
    Naleway, Allison L.
    Grannis, Shaun J.
    Ong, Toan C.
    Natarajan, Karthik
    Reese, Sarah E.
    Zerbo, Ousseny
    Kharbanda, Anupam B.
    Patel, Palak
    Stenehjem, Edward
    Raiyani, Chandni
    Irving, Stephanie A.
    Fadel, William F.
    Rao, Suchitra
    Han, Jungmi
    Reynolds, Sue
    Davis, Jonathan M.
    Lewis, Ned
    McEvoy, Charlene
    Dickerson, Monica
    Dascomb, Kristin
    Valvi, Nimish R.
    Barron, Michelle A.
    Goddard, Kristin
    Vazquez-Benitez, Gabriela
    Grisel, Nancy
    Mamawala, Mufaddal
    Embi, Peter J.
    Fireman, Bruce
    Essien, Inih J.
    Griggs, Eric P.
    Arndorfer, Julie
    Gaglani, Manjusha
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (08): : 961 - 969
  • [24] Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022
    Kim, Sara S.
    Chung, Jessie R.
    Talbot, H. Keipp
    Grijalva, Carlos G.
    Wernli, Karen J.
    Kiniry, Erika
    Martin, Emily T.
    Monto, Arnold S.
    Belongia, Edward A.
    McLean, Huong Q.
    Gaglani, Manjusha
    Mamawala, Mufaddal
    Nowalk, Mary Patricia
    Geffel, Krissy Moehling
    Tartof, Sara Y.
    Florea, Ana
    Lee, Justin S.
    Tenforde, Mark W.
    Patel, Manish M.
    Flannery, Brendan
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (06) : 975 - 985
  • [25] Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn- winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022
    Chatzilena, Anastasia
    Hyams, Catherine
    Challen, Rob
    Marlow, Robin
    King, Jade
    Adegbite, David
    Kinney, Jane
    Clout, Madeleine
    Maskell, Nick
    Oliver, Jennifer
    Finn, Adam
    Danon, Leon
    EUROSURVEILLANCE, 2023, 28 (48)
  • [26] Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years
    不详
    TRANSFUSIONSMEDIZIN, 2022, 12 (03) : 141 - 142
  • [27] Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years
    Arbel, Ronen
    Sergienko, Ruslan
    Friger, Michael
    Peretz, Alon
    Beckenstein, Tanya
    Yaron, Shlomit
    Netzer, Doron
    Hammerman, Ariel
    NATURE MEDICINE, 2022, 28 (07) : 1486 - +
  • [28] Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years
    Ronen Arbel
    Ruslan Sergienko
    Michael Friger
    Alon Peretz
    Tanya Beckenstein
    Shlomit Yaron
    Doron Netzer
    Ariel Hammerman
    Nature Medicine, 2022, 28 : 1486 - 1490
  • [29] Factors Associated With Willingness to Receive a COVID-19 Vaccine Among 23,819 Adults Aged 50 Years or Older: An Analysis of the Canadian Longitudinal Study on Aging
    Basta, Nicole E.
    Sohel, Nazmul
    Sulis, Giorgia
    Wolfson, Christina
    Maimon, Geva
    Griffith, Lauren E.
    Kirkland, Susan
    McMillan, Jacqueline M.
    Thompson, Mary
    Raina, Parminder
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2022, 191 (06) : 987 - 998
  • [30] Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged?50 years in Nordic countries: nationwide cohort study
    Andersson, Niklas Worm
    Thiesson, Emilia Myrup
    Baum, Ulrike
    Pihlstrom, Nicklas
    Starrfelt, Jostein
    Faksova, Kristyna
    Poukka, Eero
    Meijerink, Hinta
    Ljung, Rickard
    Hviid, Anders
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 382
12345